@EvidenceAllergy

👨‍🔬 Director: Dr. Derek Chu, MD PhD (@dkchu) 📋 Innovative clinical trials, guidelines, observational studies & knowledge translation 🏫 @McMasterU

 Hamilton, Ontario, Canada
evidenceinallergy.com/
Joined April 2021
  • Tweets37
  • Following32
  • Followers39
20Media
Our new international study led by researchers at @MacDeptMed @HEI_McMaster @UofT_DoM identifies the most important risk factors for food allergy development, broadening our understanding of preventing food allergies. healthsci.mcmaster.ca/what-d…

What drives food allergies? New study pinpoints early-life factors that raise risk - Faculty of...

A new study from McMaster University involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. The...

healthsci.mcmaster.ca
1
1
63
Just published review of 2.8 million participants across 190 studies identifying the risk factors associated with the development of food allergies, published in @JAMAPediatrics. Read here: jamanetwork.com/journals/jam…

Risk Factors for the Development of Food Allergy in Infants and Children

This systematic review and meta-analysis estimates the incidence of and quantifies risk factors for food allergy development in children.

jamanetwork.com
CTV News
@CTVNewsFeb 9
Babies given peanuts, fish, eggs early less likely to become allergic, study affirms ctvnews.ca/health/article/ba…

Babies given peanuts, fish, eggs early less likely to become allergic, study affirms

A new Canadian study says giving babies peanuts, eggs, fish and other common food allergens early and consistently decreases the risk they’ll be allergic to them.

ctvnews.ca
1
19
An international study led by researchers with @MacDeptMed have identified the most effective and safest treatments for chronic hives. @dkchu ow.ly/zBQ950WpUgA

Chronic hives: Researchers identify most effective, safest treatments - Faculty of Health Sciences

A new international study led by researchers at McMaster University has identified the most effective and safest treatments for people suffering from chronic urticaria, more commonly known as chronic...

healthsci.mcmaster.ca
1
1
1
430
Asthma outcomes improve with inhaled corticosteroids plus formoterol, SABA, finds study. Derek Chu (@dkchu), assistant professor @MacDeptMed, spoke with @GoHealio about the findings of the meta-analysis. ow.ly/F4YP50U0yYO

Asthma outcomes improve with inhaled corticosteroids plus formoterol, SABA

BOSTON — Combined treatments were associated with reduced asthma exacerbations compared with short-acting beta agonists alone, based on a review presented at the American College of Allergy, Asthma &...

healio.com
1
3
240
Evidence in Allergy retweeted
JAMA
@JAMA_current28 Oct 2024
Combining inhaled corticosteroids (ICS) with short-acting beta-agonists (SABA) and combining ICS with formoterol were each associated with lower risks of severe asthma exacerbations, compared to SABA alone. #ACAAI24 ja.ma/3Ysodm2
27
1
50
10,902
Do you use topical steroids to manage urticaria? See the evidence in our latest systematic review and meta-analysis, published in @AnnalsAllergy annallergy.org/article/S1081…
1
280
Did you know that Evidence in Allergy is Canada's first @worldallergy Center of Excellence? Our work advances our understanding in allergy, asthma, and clinical immunology
6
4
381
What are the comparative benefits and harms of all the topical and systemic treatments for atopic dermatitis? See @dkchu's recent interview with @GoHealio to learn all the details. healio.com/news/allergy-asth…

Reviews weigh benefits, harms of topical, systemic treatments for atopic dermatitis

With dozens of topical therapies and systemic treatments available for atopic dermatitis, clinicians have many options. But a pair of reviews in The Journal of Allergy and Clinical Immunology may...

healio.com
75
Evidence in Allergy retweeted
GlobalSkin@IADPO14 Sep 2023
TODAY IS #WorldAtopicEczemaDay! #AtopicEczema is more than itchy skin, it is a systemic, multidimensional disease that affects the minds & bodies of people around the world - especially youth. globalskin.org/WAED2023 #GlobalSkin #ShareTheBurden #IfYouOnlyKnew
14
1
30
2,245
Findings from a recent review on topical therapy options for patients with atopic dermatitis (AD) have important and immediate implications for achieving optimal AD outcomes, says Derek Chu (@dkchu), assistant professor @MacDeptMed ow.ly/Sl8C50PKfrT
Person applying lotion to red skin

ALT Person applying lotion to red skin

1
1
505
Thank you to everyone for sharing their comments and feedback on our draft 2023 #AtopicDermatitis Practice Parameter Update. Read the final guideline soon in @AnnalsAllergy The Joint Task Force on Practice Parameters is sponsored by the @AAAAI_org and @ACAAI
1
108
🚨 Topical treatments are the mainstay for managing #AtopicDermatitis, but with so many options available, how do we choose the best one? Read the new #SystematicReview and network meta-analysis, now published in @jacionline 📄jacionline.org/article/S0091…
Blue text on white background that reads: "What's the best topical treatment option for atopic dermatitis? We analyzed 68 treatments across 43,123 participants in 219 RCTs to find out. Now published in JACI." A cartoon image of assorted tubes and bottles of creams and ointments in a box is on the left.

ALT Blue text on white background that reads: "What's the best topical treatment option for atopic dermatitis? We analyzed 68 treatments across 43,123 participants in 219 RCTs to find out. Now published in JACI." A cartoon image of assorted tubes and bottles of creams and ointments in a box is on the left.

1
1
1
943
❕RESULTS❕ @dkchu and team compared patient-important outcomes among 68 treatments across 43,123 participants in 219 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians
1
148
📢NOW PUBLISHED📢 Discover the most effective and safest systemic treatments for #AtopicDermatitis. Read the latest #SystematicReview and network meta-analysis, now available in @jacionline 📃jacionline.org/article/S0091…
White text on blue background that reads: "What's the best systemic treatment option for atopic dermatitis? We analyzed 75 treatments across 28,686 participants in 149 RCTs to find out. Now published in JACI." A cartoon image of assorted pills and syringes in a box is on the right.

ALT White text on blue background that reads: "What's the best systemic treatment option for atopic dermatitis? We analyzed 75 treatments across 28,686 participants in 149 RCTs to find out. Now published in JACI." A cartoon image of assorted pills and syringes in a box is on the right.

1
4
3
4
3,080
❗RESULTS❗@alexandro_chu and team compared patient-important outcomes among 75 treatments across 28,686 participants in 149 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians
3
183
Evidence in Allergy retweeted
National Eczema@nationaleczema5 Sep 2023
Let’s step back in time to discover the major milestones in #eczema’s history and, perhaps, catch a glimpse of the future. Learn more about eczema's origin story: nationaleczema.org/blog/the-… #GetEczemaWise #atopicdermatitis #dermtwitter
2
311
We're studying new treatment options for people with tree nut #allergies. Have a tree nut allergy and want to learn more? Contact us: evidenceinallergy.com/contac…
The Evidence in Allergy and TRADE logos at the top. The text reads: "Have a tree nut allergy and interested in new treatments? Contact us to learn more and get involved evidenceinallergy.com/contact ". An image of tree nuts on the right.

ALT The Evidence in Allergy and TRADE logos at the top. The text reads: "Have a tree nut allergy and interested in new treatments? Contact us to learn more and get involved evidenceinallergy.com/contact ". An image of tree nuts on the right.

1
1
313
#ICYMI Moderate-certainty evidence shows that topical calcineurin inhibitors do not increase cancer risk in patients with #eczema. Our findings support the safe use of tacrolimus and pimecrolimus. @LancetChildAdol thelancet.com/journals/lanch…
Graphic that writes "In patients with atopic dermatitis, typical usage of tacrolimus and pimecrolimus do not increase the risk of cancer" with "GRADE moderate certainty" evidence. An image of the first page of the associated journal article is displayed.

ALT Graphic that writes "In patients with atopic dermatitis, typical usage of tacrolimus and pimecrolimus do not increase the risk of cancer" with "GRADE moderate certainty" evidence. An image of the first page of the associated journal article is displayed.

1
1
1
823
#DYK that there are 7 different types of #eczema? Treatment options may vary depending on what type you have and it is important to understand the differences. Take a journey with us to guide you through the 7 types of eczema: allergyasthmanetwork.org/wha…
1
5
1
7
745
We are partnering with @AAAAI_org & @ACAAI to develop an evidence-based, patient-centered guideline on severe asthma. We are seeking patients & caregivers with lived experience to join our guideline group. If interested, please complete this interest form forms.gle/6nrPeKVsGs9QQM4d9
113
Load more